Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer

Chen Zhang1, Xiyi Lu1, Xinyin Liu1

  • 1Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China.

Insights

Carbonic anhydrase IX (CA9) drives resistance to EGFR-TKI therapy in lung cancer by blocking ferroptosis. Targeting CA9 restores ferroptosis, offering a new strategy to overcome gefitinib resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) is a significant challenge in lung cancer treatment.
  • Ferroptosis-inducing therapy shows potential against EGFR-TKI resistant cancers but lacks clinical translation.

Purpose of the Study:

  • To investigate the role of carbonic anhydrase IX (CA9) in gefitinib-resistant lung cancer.
  • To explore CA9 as a therapeutic target to overcome resistance by inducing ferroptosis.

Main Methods:

  • Upregulation of CA9 in gefitinib-resistant lung cancer cells was identified.
  • Cell viability, reactive oxygen species (ROS), and labile iron levels were measured after erastin treatment.
  • Mechanisms of CA9-mediated ferroptosis resistance were investigated, including transferrin endocytosis and ferritin stabilization.

Main Results:

  • CA9 was found to confer resistance to ferroptosis-inducing drugs by inhibiting transferrin endocytosis and stabilizing ferritin.
  • Targeting CA9 promoted iron uptake and release, inducing ferroptosis in gefitinib-resistant cells.
  • A CA9 inhibitor enhanced cisplatin's ferroptosis-inducing effect, leading to the elimination of resistant cells in heterogeneous tumors.

Conclusions:

  • CA9 plays a critical role in mediating resistance to ferroptosis in lung cancer.
  • Targeting CA9 is a promising therapeutic strategy to enhance the efficacy of gefitinib and overcome treatment resistance by inducing ferroptosis.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
321